Cara Therapeutics | CARA - SCHULD

Aktienkurs
4.18
Täglich Wechseln
-0.03 -0.71%
Monatlich
41.22%
Jährlich
-83.68%
Q2 Prognose
3.07




SCHULD Veränderung Datum
Acadia Pharmaceuticals USD 52.19M 2.62M 2025-12
Alterity Therapeutics Limited AUD 210.39K 120.67K 2023-06
Assertio Holdings USD 38.87M 615K 2023-09
Cara Therapeutics USD 0 0 2025-03
Cassava Sciences USD 0 0 2024-12
Chugai Pharma JPY 14.11B 1.93B 2022-12
Cipla INR 4.38B 231.9M 2025-03
Clal Biotechnology ILS 35.76M 28.27M 2023-12
Compugen USD 2.95M 24K 2025-09
CSL USD 11.96B 219M 2024-12
Grifols EUR 9.23B 626.05M 2024-12
Halozyme Therapeutics USD 1.51B 1.66M 2025-09
J&J USD 47.93B 2.14B 2025-12
Neurocrine Biosciences USD 415.3M 13.1M 2025-12
Pacira USD 367.66M 4.53M 2026-03
Pfizer USD 63.96B 3.11B 2025-12
RedHill Biopharma USD 214K 142K 2025-06
Supernus Pharmaceuticals USD 40.98M 1.23M 2025-12
Vanda Pharmaceuticals USD 4.96M 4.96M 2024-12